Search - tctmd.com

Displaying 1 - 20 of 331

Sort: Relevancy | Date

News Conference News CRT 2026

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

L.A. McKeown

March 16, 2026

News Conference News CRT 2026

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

L.A. McKeown

March 11, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

Presentation CTO 2026

Current Examples of Observational Studies in Coronary Revascularization – When to do a Single Arm Study and How to Analyze Large Datasets

Presenter: David J. Cohen

February 13, 2026

Presentation CTO 2026

Current Examples of Randomized Trials in Coronary Revascularization - Why Non-Inferiority and What is the WIN Ratio?

Presenter: David J. Cohen

February 13, 2026

News Conference News STS 2026

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

Yael L. Maxwell

February 10, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

How Does Real World Evidence Fit into the Regulatory Pathway?

Presenter: David J. Cohen

October 28, 2025

Presentation TCT 2025

TCT 1047: Rising Use of Thrombectomy in Acute Pulmonary Embolism: Mortality Benefits in Cor Pulmonale and the Role of Hyponatremia

Presenter: Brett David Cohen

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

Clinical Research After TRISCEND: Highest Priority Clinical Questions

Presenter: David J. Cohen

October 26, 2025

Presentation TCT 2025

TCT 299: Impact of Coronary Artery Bypass Graft and Cardiac Catheterization Timing on Mortality and Disability in NSTEMI Patients

Presenter: Brett David Cohen

October 26, 2025

Presentation TCT 2025

Power in Partnership: Why I Champion the Cardiovascular Team

Presenter: David J. Cohen

October 25, 2025

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Todd Neale

October 22, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Advertisement

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Current Examples of Observational Studies in Coronary Revascularization – When to do a Single Arm Study and How to Analyze Large Datasets

Current Examples of Randomized Trials in Coronary Revascularization - Why Non-Inferiority and What is the WIN Ratio?

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

How Does Real World Evidence Fit into the Regulatory Pathway?

TCT 1047: Rising Use of Thrombectomy in Acute Pulmonary Embolism: Mortality Benefits in Cor Pulmonale and the Role of Hyponatremia

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Clinical Research After TRISCEND: Highest Priority Clinical Questions

TCT 299: Impact of Coronary Artery Bypass Graft and Cardiac Catheterization Timing on Mortality and Disability in NSTEMI Patients

Power in Partnership: Why I Champion the Cardiovascular Team

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

What’s Going to Be Hot at TCT 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content